JP2012502048A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502048A5
JP2012502048A5 JP2011526202A JP2011526202A JP2012502048A5 JP 2012502048 A5 JP2012502048 A5 JP 2012502048A5 JP 2011526202 A JP2011526202 A JP 2011526202A JP 2011526202 A JP2011526202 A JP 2011526202A JP 2012502048 A5 JP2012502048 A5 JP 2012502048A5
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl group
unsubstituted
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011526202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012502048A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/055927 external-priority patent/WO2010028175A1/en
Publication of JP2012502048A publication Critical patent/JP2012502048A/ja
Publication of JP2012502048A5 publication Critical patent/JP2012502048A5/ja
Pending legal-status Critical Current

Links

JP2011526202A 2008-09-08 2009-09-03 アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法 Pending JP2012502048A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9522708P 2008-09-08 2008-09-08
US61/095,227 2008-09-08
PCT/US2009/055927 WO2010028175A1 (en) 2008-09-08 2009-09-03 Modulators of aldehyde dehydrogenase activity and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014208930A Division JP2015051983A (ja) 2008-09-08 2014-10-10 アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法

Publications (2)

Publication Number Publication Date
JP2012502048A JP2012502048A (ja) 2012-01-26
JP2012502048A5 true JP2012502048A5 (en:Method) 2012-10-18

Family

ID=41797485

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011526202A Pending JP2012502048A (ja) 2008-09-08 2009-09-03 アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
JP2014208930A Pending JP2015051983A (ja) 2008-09-08 2014-10-10 アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014208930A Pending JP2015051983A (ja) 2008-09-08 2014-10-10 アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法

Country Status (7)

Country Link
US (3) US8354435B2 (en:Method)
EP (1) EP2337563B1 (en:Method)
JP (2) JP2012502048A (en:Method)
CN (1) CN102209541B (en:Method)
ES (1) ES2477552T3 (en:Method)
TW (1) TWI464161B (en:Method)
WO (1) WO2010028175A1 (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110105602A2 (en) 2007-03-08 2011-05-05 Daria Mochly-Rosen Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof
US8354435B2 (en) 2008-09-08 2013-01-15 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase activity and methods of use thereof
WO2010062308A1 (en) 2008-10-28 2010-06-03 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase and methods of use thereof
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
CA2839703A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
TWI567061B (zh) 2011-07-01 2017-01-21 吉李德科學股份有限公司 用於治療成癮之化合物
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
FR3054564B1 (fr) * 2016-07-28 2018-08-31 Advanced Biodesign Substrat specifique d'une isoenzyme de l'aldh
CN117105868A (zh) * 2022-05-24 2023-11-24 中国人民解放军海军军医大学 酰胺类醛脱氢酶激动剂、其合成方法及用途
CN115160285B (zh) * 2022-08-25 2022-11-29 云南大学 硫代酰胺类aldh2激动剂、制备方法及应用

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2319808A (en) 1939-08-31 1943-05-25 Squibb & Sons Inc Sterol derivatives and process for producing same
DE2417763A1 (de) 1974-04-11 1975-10-30 Bayer Ag Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4992418A (en) 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
JPH01203351A (ja) 1988-02-05 1989-08-16 Mitsui Petrochem Ind Ltd 1,4−ジヒドロキシナフタレン誘導体および医薬
JPH023351A (ja) 1988-06-16 1990-01-08 Oki Electric Ind Co Ltd 印刷装置
US4861891A (en) 1988-08-31 1989-08-29 Pfizer Inc. Antidepressant N-substituted nicotinamide compounds
US5514646A (en) 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
JPH03184973A (ja) 1989-12-14 1991-08-12 Rooman Kogyo:Kk 放射線障害防護剤
US5260323A (en) * 1990-06-28 1993-11-09 Hoechst Aktiengesellschaft 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
TW197439B (en:Method) 1991-04-04 1993-01-01 Ueno Pharmaceutics Applic Res Co Ltd
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
DE4201047A1 (de) 1992-01-17 1993-07-22 Bayer Ag Substituierte isoxazolcarbonsaeureamide
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
US5294637A (en) 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
JP2994182B2 (ja) 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
US5202448A (en) 1992-08-14 1993-04-13 Napro Biotherapeutics, Inc. Processes of converting taxanes into baccatin III
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5461031A (en) 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
JP3833281B2 (ja) * 1995-02-03 2006-10-11 日本曹達株式会社 2,6−ジクロロイソニコチン酸ベンジルアミド誘導体及び植物病害防除剤
YU18596A (sh) 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
WO1997010223A1 (en) * 1995-09-15 1997-03-20 Pharmacia & Upjohn Company Aminoaryl oxazolidinone n-oxides
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
FR2751645B1 (fr) 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
ZA984697B (en) 1997-06-13 1999-12-01 Lilly Co Eli Stable insulin formulations.
CN1327443A (zh) 1997-10-31 2001-12-19 艾文蒂斯药品有限公司 取代的酰苯胺化合物
JP2002511386A (ja) 1997-12-22 2002-04-16 イーライ・リリー・アンド・カンパニー アミド形成反応のための触媒およびその方法
EP1080069B1 (en) 1998-04-20 2003-03-19 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
AR019190A1 (es) * 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
US6780883B2 (en) * 1998-11-05 2004-08-24 Warner-Lambert Company Amide inhibitors of microsomal triglyceride transfer protein
WO2000031060A1 (en) 1998-11-25 2000-06-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
GB9919558D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
AU1466001A (en) 1999-11-05 2001-05-14 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent
WO2001079489A2 (en) 2000-04-18 2001-10-25 Millennium Pharmaceuticals, Inc. 39228, a human alcohol dehydrogenase and uses therefor
US7179912B2 (en) 2000-09-01 2007-02-20 Icos Corporation Materials and methods to potentiate cancer treatment
BR0113931A (pt) 2000-09-15 2004-01-13 Anormed Inc Compostos heterocìclicos ligantes receptores de quimiocinas
IL154227A0 (en) * 2000-09-15 2003-07-31 Anormed Inc Chemokine receptor binding heterocyclic compounds
US7141590B2 (en) 2000-12-29 2006-11-28 Ucb Sa Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
US6678516B2 (en) 2001-05-21 2004-01-13 Nokia Corporation Method, system, and apparatus for providing services in a privacy enabled mobile and Ubicom environment
EP1402890B1 (en) 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
JPWO2003030937A1 (ja) 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
DE10149674A1 (de) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
US20030100034A1 (en) * 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
KR20040077884A (ko) * 2002-01-31 2004-09-07 화이자 프로덕츠 인코포레이티드 (3-{〔(4-3급-뷰틸-벤질)-(피리딘-3-설폰일)-아미노〕-메틸}-페녹시)-아세트산의 대사산물
EP1477186B1 (en) 2002-02-19 2009-11-11 Shionogi & Co., Ltd. Antipruritics
JP4595059B2 (ja) 2002-04-18 2010-12-08 株式会社医薬分子設計研究所 アミド誘導体
GB0215650D0 (en) 2002-07-05 2002-08-14 Cyclacel Ltd Bisarylsufonamide compounds
KR20050049485A (ko) 2002-09-06 2005-05-25 엘란 파마슈티칼스, 인크. 1,3-디아미노-2-히드록시프로판 전구약물 유도체
EP1402888A1 (en) 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors
EP1402887A1 (en) 2002-09-18 2004-03-31 Jerini AG New compounds for the inhibition of undesired cell proliferation and use thereof
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7022850B2 (en) 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
JP4359754B2 (ja) * 2003-07-03 2009-11-04 三菱瓦斯化学株式会社 基板の洗浄剤
JP2007528717A (ja) 2003-07-21 2007-10-18 オンコセラピー・サイエンス株式会社 結腸直腸癌を診断する方法
WO2005011561A2 (en) 2003-08-04 2005-02-10 Labcoat, Ltd. Stent coating apparatus and method
GB0318814D0 (en) * 2003-08-11 2003-09-10 Smithkline Beecham Corp Novel compounds
CN1867339A (zh) 2003-08-18 2006-11-22 盐野义制药株式会社 大麻素受体拮抗剂的新应用
FR2861074B1 (fr) 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
WO2005057213A1 (en) 2003-12-09 2005-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
GT200500013A (es) * 2004-01-23 2005-08-10 Amidas herbicidas
WO2005084392A2 (en) 2004-03-03 2005-09-15 Convivia 4-methylpyrazole formulations for inhibiting ethanol intolerance
JP2007538024A (ja) 2004-05-19 2007-12-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アミロイドベータペプチドのレベル変化に関連する疾患及び状態の治療方法及び新規エノールカルボキサミド化合物
CN1749415A (zh) 2004-09-15 2006-03-22 上海人类基因组研究中心 硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒
US7456194B2 (en) * 2004-11-12 2008-11-25 Bristol-Myers Squibb Company Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
US7888374B2 (en) * 2005-01-28 2011-02-15 Abbott Laboratories Inhibitors of c-jun N-terminal kinases
DOP2006000051A (es) 2005-02-24 2006-08-31 Lilly Co Eli Inhibidores de vegf-r2 y métodos
GEP20115230B (en) 2005-09-23 2011-06-10 Pfizer Prod Inc Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4
AU2006331765A1 (en) 2005-12-22 2007-07-05 Wyeth Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and use thereof as kinase inhibitor
JP2009531364A (ja) 2006-03-28 2009-09-03 ノバルティス アクチエンゲゼルシャフト アミド誘導体およびgタンパク質関連疾患の処置のためのそれらの使用
EP2727585A1 (en) * 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo screening method
WO2007136707A2 (en) 2006-05-17 2007-11-29 University Of Utah Research Foundation Methods and compositions related to eosinophil regulation
US20080003585A1 (en) 2006-06-29 2008-01-03 Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware Purification and amplification of nucleic acids in a microfluidic device
KR20090033417A (ko) 2006-07-27 2009-04-03 씨브이 쎄러퓨틱스, 인코포레이티드 중독의 치료에서의 aldh-2 저해제
PE20080906A1 (es) 2006-08-17 2008-07-05 Kemia Inc Derivados heteroarilo como inhibidores de citocina
US8927715B2 (en) 2006-08-25 2015-01-06 Vitae Pharmaceuticals, Inc. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
ATE507205T1 (de) * 2006-12-11 2011-05-15 Genetics Co Inc Aromatische 1,4-di-carboxylamide und deren verwendung
MX2009006863A (es) 2006-12-20 2009-08-28 Schering Corp Inhibidores novedosos de c-jun-n-terminal cinasas.
WO2008082487A2 (en) * 2006-12-20 2008-07-10 Schering Corporation Novel jnk inhibitors
US20080200461A1 (en) 2007-02-20 2008-08-21 Cropsolution, Inc. Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
US20110105602A2 (en) 2007-03-08 2011-05-05 Daria Mochly-Rosen Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009137045A2 (en) 2008-05-07 2009-11-12 The Board Of Trustees Of The Leland Stanford Junior University Crystal structure of aldehyde dehydrogenase and methods of use thereof
EP2300433A4 (en) * 2008-06-04 2012-03-07 Ambrilia Biopharma Inc HIV INTEGRASE INHIBITORS FROM PYRIDOXIN
PE20110136A1 (es) 2008-06-27 2011-03-17 Novartis Ag Compuestos organicos
US8354435B2 (en) 2008-09-08 2013-01-15 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase activity and methods of use thereof
WO2010062308A1 (en) 2008-10-28 2010-06-03 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase and methods of use thereof
JP5685203B2 (ja) 2009-05-29 2015-03-18 ラクオリア創薬株式会社 カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体
MX367623B (es) 2010-10-20 2019-08-29 Gruenenthal Gmbh 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
WO2012082862A2 (en) 2010-12-14 2012-06-21 Beth Israel Deaconess Medical Center Androgen receptor inhibitors and methods of use thereof
WO2012106534A2 (en) 2011-02-02 2012-08-09 The Regents Of The University Of California Hiv integrase inhibitors
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
SG11201400310WA (en) 2011-08-29 2014-06-27 Infinity Pharmaceuticals Inc Heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2012502048A5 (en:Method)
JP2015051983A5 (en:Method)
JP2010514786A5 (en:Method)
JP2010529147A5 (en:Method)
JP2013508279A5 (en:Method)
JP2008195730A5 (en:Method)
JP2017535610A5 (en:Method)
JP2013510120A5 (en:Method)
JP2017518959A5 (en:Method)
JP2009263394A5 (en:Method)
JP2016505595A5 (en:Method)
JP2009143956A5 (en:Method)
JP2011516511A5 (en:Method)
JP2017523225A5 (en:Method)
JP2012512907A5 (en:Method)
JP2013537203A5 (en:Method)
JP2018135343A5 (en:Method)
JP2009543795A5 (en:Method)
JP2009536191A5 (en:Method)
JP2009532417A5 (en:Method)
JP2010090149A5 (en:Method)
JP2007526257A5 (en:Method)
JP2013518036A5 (en:Method)
JP2014530838A5 (en:Method)
JP2010522710A5 (en:Method)